ClinicalTrials.Veeva

Menu

Changes in Bruxism Activity After Periodontal Treatment in Patients With Periodontitis

U

University of Siena

Status

Completed

Conditions

Periodontitis
Bruxism
Awake Bruxism
Sleep Bruxism

Treatments

Procedure: Non-Surgical Periodontal Therapy (Step 1 & 2)
Procedure: Supragingival Plaque Removal and Polishing

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This controlled pre-post study evaluates the effect of non-surgical periodontal therapy on awake and sleep bruxism in patients with Stage III and IV periodontitis. Bruxism activity and periodontal status will be assessed at baseline and three months after treatment.

Full description

This is a non-randomized controlled pre-post clinical study designed to investigate the impact of periodontal treatment on awake and sleep bruxism in individuals with advanced periodontitis. Two groups will be included: a periodontitis group undergoing full non-surgical periodontal therapy (step 1 and 2), and a healthy control group receiving supragingival plaque removal and polishing. All participants will receive standardized oral hygiene instructions and motivation. Bruxism activity will be recorded using portable electromyography (EMG) devices at baseline and after three months, evaluating both sleep and awake bruxism through Bruxism Work Index (BWI) and Bruxism Time Index (BTI). Clinical periodontal parameters will also be collected at both time points to assess potential correlations with bruxism variation.

Enrollment

40 patients

Sex

All

Ages

25 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 25 and 50 years
  • Good general health (ASA I or II)
  • Signed informed consent
  • Willingness to attend all study visits and follow instructions
  • For periodontitis group: diagnosis of Stage III or IV periodontitis according to the 2017 classification
  • For healthy control group: no clinical signs of periodontitis

Exclusion criteria

  • Systemic diseases or medications affecting the periodontium (e.g., diabetes, immunosuppressants)
  • Antibiotic or anti-inflammatory therapy within the last 3 months
  • Periodontal treatment in the last 6 months
  • Smoking more than 10 cigarettes/day
  • Use of occlusal splints or bruxism-targeted therapy in the past 6 months
  • Pregnancy or lactation
  • Any condition impairing the ability to cooperate or comply with the study protocol

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Periodontitis Group
Experimental group
Description:
Participants with Stage III or IV periodontitis will receive full non-surgical periodontal therapy (step 1 and step 2), along with standardized oral hygiene instructions and motivation. Bruxism activity and periodontal status will be assessed at baseline and after three months.
Treatment:
Procedure: Non-Surgical Periodontal Therapy (Step 1 & 2)
Healthy Control Group
Active Comparator group
Description:
Periodontally healthy participants will receive supragingival plaque removal and polishing, along with standardized oral hygiene instructions and motivation. Bruxism activity and periodontal status will be assessed at baseline and after three months.
Treatment:
Procedure: Supragingival Plaque Removal and Polishing

Trial contacts and locations

1

Loading...

Central trial contact

Nicola Discepoli, DDS, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems